<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">73853</article-id><article-id pub-id-type="doi">10.7554/eLife.73853</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Targeting the Annexin A1-FPR2/ALX pathway for host-directed therapy in dengue disease</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-84445"><name><surname>Costa</surname><given-names>Vivian Vasconcelos</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0175-642X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-256896"><name><surname>Sugimoto</surname><given-names>Michelle A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4527-6065</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258102"><name><surname>Hubner</surname><given-names>Josy</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258103"><name><surname>Bonilha</surname><given-names>Caio S</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188914"><name><surname>Queiroz-Junior</surname><given-names>Celso Martins</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258104"><name><surname>Gonçalves-Pereira</surname><given-names>Marcela Helena</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258105"><name><surname>Chen</surname><given-names>Jianmin</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258106"><name><surname>Gobbetti</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258107"><name><surname>Libanio Rodrigues</surname><given-names>Gisele Olinto</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258108"><name><surname>Bambirra</surname><given-names>Jordana L</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258109"><name><surname>Passos</surname><given-names>Ingredy B</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258110"><name><surname>Machado Lopes</surname><given-names>Carla Elizabeth</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258111"><name><surname>Moreira</surname><given-names>Thaiane P</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258112"><name><surname>Bonjour</surname><given-names>Kennedy</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258113"><name><surname>Melo</surname><given-names>Rossana CN</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258114"><name><surname>Oliveira</surname><given-names>Milton AP</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258115"><name><surname>Andrade</surname><given-names>Marcus Vinicius M</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258893"><name><surname>Sousa</surname><given-names>Lirlândia Pires</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1042-9762</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-5299"><name><surname>Souza</surname><given-names>Danielle Gloria</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258179"><name><surname>Santiago</surname><given-names>Helton da Costa</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-221146"><name><surname>Perretti</surname><given-names>Mauro</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2068-3331</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-66947"><name><surname>Teixeira</surname><given-names>Mauro Martins</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6944-3008</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Morphology</institution>, <institution>Universidade Federal de Minas Gerais</institution>, <addr-line><named-content content-type="city">Belo Horizonte</named-content></addr-line>, <country>Brazil</country></aff><aff id="aff2"><institution>Queen Mary University of London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">Department of Biochemistry and Immunology</institution>, <institution>Universidade Federal de Minas Gerais</institution>, <addr-line><named-content content-type="city">Belo Horizonte</named-content></addr-line>, <country>Brazil</country></aff><aff id="aff4"><institution content-type="dept">Department of Microbiology</institution>, <institution>Universidade Federal de Minas Gerais</institution>, <addr-line><named-content content-type="city">Belo Horizonte</named-content></addr-line>, <country>Brazil</country></aff><aff id="aff5"><institution content-type="dept">Department of Biology</institution>, <institution>Federal University of Juiz de Fora</institution>, <addr-line><named-content content-type="city">Juiz de Fora</named-content></addr-line>, <country>Brazil</country></aff><aff id="aff6"><institution content-type="dept">Tropical Pathology and Public Health Institute</institution>, <institution>Universidade Federal de Goiás</institution>, <addr-line><named-content content-type="city">Goiania</named-content></addr-line>, <country>Brazil</country></aff><aff id="aff7"><institution content-type="dept">School of Medicine</institution>, <institution>Universidade Federal de Minas Gerais</institution>, <addr-line><named-content content-type="city">Belo Horizonte</named-content></addr-line>, <country>Brazil</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-21373"><name><surname>Kirchhoff</surname><given-names>Frank</given-names></name><role>Reviewing editor</role><aff><institution>Ulm University Medical Center</institution>, <country>Germany</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>m.perretti@qmul.ac.uk</email> (MP);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>mmtex.ufmg@gmail.com</email> (MT);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>16</day><month>03</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e73853</elocation-id><history><date date-type="received"><day>14</day><month>09</month><year>2021</year></date><date date-type="accepted"><day>15</day><month>03</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Costa et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Costa et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-73853-v1.pdf"/><abstract><p>Host immune responses contribute to dengue's pathogenesis and severity, yet the possibility that failure in endogenous inflammation resolution pathways could characterise the disease has not been contemplated. The pro-resolving protein Annexin A1 (AnxA1) is known to counterbalance overexuberant inflammation and mast cell (MC) activation. We hypothesised that inadequate AnxA1 engagement underlies the cytokine storm and vascular pathologies associated with dengue disease. Levels of AnxA1 were examined in the plasma of dengue patients and infected mice. Immunocompetent, interferon (alpha and beta) receptor 1 knockout (KO), AnxA1 KO<sup> </sup>and FPR2 KO mice were infected with <italic>Dengue virus</italic> (DENV) and treated with the AnxA1 mimetic peptide Ac<sub>2-26</sub> for analysis. Additionally, the effect of Ac<sub>2-26 </sub>on DENV-induced MC degranulation was assessed <italic>in vitro </italic>and <italic>in vivo</italic>. We observed that circulating levels of AnxA1 were reduced in dengue patients and DENV-infected mice. While the absence of AnxA1 or its receptor FPR2 aggravated illness in infected mice, treatment with AnxA1 agonistic peptide attenuated disease manifestations. Both clinical outcomes were attributed to modulation of DENV-mediated viral load-independent MC degranulation. We have thereby identified that altered levels of the pro-resolving mediator AnxA1 are of pathological relevance in DENV infection, suggesting FPR2/ALX agonists as a therapeutic target for dengue disease.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd><kwd>Viruses</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004901</institution-id><institution>Fundação de Amparo à Pesquisa do Estado de Minas Gerais</institution></institution-wrap></funding-source><award-id>Fapemig Hospedeiro em Dengue project</award-id><principal-award-recipient><name><surname>Teixeira</surname><given-names>Mauro Martins</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MR/No17544/1</award-id><principal-award-recipient><name><surname>Sousa</surname><given-names>Lirlândia Pires</given-names></name><name><surname>Souza</surname><given-names>Danielle Gloria</given-names></name><name><surname>Santiago</surname><given-names>Helton da Costa</given-names></name><name><surname>Perretti</surname><given-names>Mauro</given-names></name><name><surname>Teixeira</surname><given-names>Mauro Martins</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003593</institution-id><institution>Conselho Nacional de Desenvolvimento Científico e Tecnológico</institution></institution-wrap></funding-source><award-id>Instituto Nacional de Ci&amp;#x00EA;ncia e Tecnologia em Dengue</award-id><principal-award-recipient><name><surname>Sousa</surname><given-names>Lirlândia Pires</given-names></name><name><surname>Souza</surname><given-names>Danielle Gloria</given-names></name><name><surname>Teixeira</surname><given-names>Mauro Martins</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004901</institution-id><institution>Fundação de Amparo à Pesquisa do Estado de Minas Gerais</institution></institution-wrap></funding-source><award-id>Instituto Nacional de Ci&amp;#x00EA;ncia e Tecnologia em Dengue</award-id><principal-award-recipient><name><surname>Sousa</surname><given-names>Lirlândia Pires</given-names></name><name><surname>Souza</surname><given-names>Danielle Gloria</given-names></name><name><surname>Teixeira</surname><given-names>Mauro Martins</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002322</institution-id><institution>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior</institution></institution-wrap></funding-source><award-id>Finance Code 001</award-id><principal-award-recipient><name><surname>Sugimoto</surname><given-names>Michelle A</given-names></name><name><surname>Teixeira</surname><given-names>Mauro Martins</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>L'Oréal-UNESCO-ABC</institution></institution-wrap></funding-source><award-id>Para Mulheres na Ci&amp;#x00EA;ncia prize&quot;</award-id><principal-award-recipient><name><surname>Costa</surname><given-names>Vivian Vasconcelos</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002322</institution-id><institution>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior</institution></institution-wrap></funding-source><award-id>P&amp;#x00F3;s-Doutorado/Capes (PNPD /CAPES)</award-id><principal-award-recipient><name><surname>Sugimoto</surname><given-names>Michelle A</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Mauro Perretti, MP is on the Scientific Advisory Board of ResoTher Pharma AS, which is interested in developing Annexin A1-derived peptides for cardiovascular settings..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the Brazilian Government's ethical and animal experiments regulations (Law 11794/2008) and the recommendations of the CONCEA (Conselho Nacional de Controle de Experimentação Animal) from Brazil. All animal experiments received prior approval from the Animal Ethics Committee (CEUA) of Universidade Federal de Minas Gerais (UFMG), Brazil (Protocol numbers: 169/2016 and 234/2019). All surgeries were performed under ketamine/xylazine anaesthesia, and every effort was made to minimise animal suffering.</p></fn><fn fn-type="other"><p>Human subjects: Human sample collection was approved by the Committee on Ethics in Research of the Universidade Federal de Minas Gerais (Protocol Numbers 24832513.4.0000.5149 and 66128617.6.0000.5149). All patients have provided signed informed consent.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data has been included in the manuscript, and source data files have been provided for Figures 1-6.</p></sec><supplementary-material><ext-link xlink:href="elife-73853-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>